Published in
American Chemical Society, Journal of Medicinal Chemistry, 12(64), p. 8486-8509, 2021
DOI: 10.1021/acs.jmedchem.1c00420
Links
Tools
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia
Journal article published in 2021 by
Krimo Toutah,
Nabanita Nawar,
Sanna Timonen,
Helena Sorger 
,
Yasir S. Raouf,
Shazreh Bukhari,
Jana von Jan,
Aleksandr Ianevski,
Justyna M. Gawel,
Olasunkanmi O. Olaoye,
Mulu Geletu,
Ayah Abdeldayem,
Johan Israelian,
Tudor B. Radu,
Abootaleb Sedighi
and other authors.
,
Yasir S. Raouf,
Shazreh Bukhari,
Jana von Jan,
Aleksandr Ianevski,
Justyna M. Gawel,
Olasunkanmi O. Olaoye,
Mulu Geletu,
Ayah Abdeldayem,
Johan Israelian,
Tudor B. Radu,
Abootaleb Sedighi
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 